生物科技IPO热潮延续!高盛系免疫疗法新锐Attovia(ATTO.US)IPO募资2.89亿美元,今晚登陆纳斯达克

智通财经
Aug 05
【生物科技IPO热潮延续!高盛系免疫疗法新锐Attovia(ATTO.US)IPO募资2.89亿美元,今晚登陆纳斯达克】智通财经APP获悉,专注于免疫系统疾病领域、致力于满足巨大未满足临床需求的早期生物制药公司Attovia Therapeutics Inc.(ATTO.US),近日在美国首次公开募股(IPO)中以发行价区间上限成功定价,募集资金达2.89亿美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10